Chilled painkiller could cool down Post-Root-Canal pain
NCT ID NCT06584188
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two ways of using an anti-inflammatory drug (ketorolac) during root canal treatment: one at room temperature and one chilled. The goal is to see if the cold version reduces pain better after the procedure. Sixty adults with tooth infections will be enrolled, and pain levels will be measured using a standard pain scale.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ketorolac tromethamine
- What this could lead to
- If it works, this could offer a better way to manage pain after root canal treatment.
- What could go wrong
- This is a small, early Phase 2 trial. The cold version may not work better than the room-temperature version, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients that will be diagnosed with symptomatic irreversible pulpitis and apical periodontitis. 2. Patient age ranging from 18-40 years. 3. Males or females. 4. Lower premolars. 5. Medically free patients. 6. Teeth with mature apex. 7. Teeth without any type of root resorption. Exclusion Criteria: 1. Patients with other pulpal diagnosis. 2. Medically compromised patients. 3. Vulnerable group; pregnant females, mentally ill, etc... 4. Patients taking analgesics or anti-inflammatory drugs. 5. Teeth with open apex.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Apical periodontitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Faculty of Dentistry, Ain Shams University
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two nerve blocks go head to head for chest surgery pain
- Can a Nurse's confidence ease a Patient's postoperative pain?
- Antidepressant may double as pain reliever after gallbladder surgery
- Nerve blocks put to the test for breast surgery pain
- A Non-Opioid pain drug takes aim at Surgery's opioid problem
- Can a nerve block stop pain months after hysterectomy?